spacer
home > pmps > spring 2017 > packaging for people
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Packaging for People

Developments in Europe since the first EU legislation in 1992 have led to a substantial standardisation of medicinal packaging. The law demands a combination of outer packaging, an inner container and a leaflet, and most drugs across Europe are now packed in a very similar way. This, of course, has major benefits for the pharmaceutical trade and for regulatory controls as it is relatively easy to compare prices and check legal compliance.

However, the perspective of the actual user is rarely considered. One reason might be that this point of view is more difficult to quantify and control. There are different ways in which drugs can be obtained (with or without a prescription) and numerous situations in which they are used (home, hospital, emergency). They are handled by several different people (healthcare professionals, carers, patients), all of whom differ in age, experience, language and reading abilities. Until now, this variety has been almost completely ignored in the packaging designs – there is only a ‘one-size-fits-all’ standard.

A second reason that the user perspective has not attracted much attention might be that production developments and continuous modifications to the regulations about packaging and leaflets has demanded most of the time and effort. There is rarely any time to consider what the consequences of legal compliance are on the people who handle medicines in care situations.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Karel van der Waarde is a researcher and consultant for Graphic Design- Research, a company that writes, designs and tests packaging, package inserts and visual information about medicines. The focus is on a direct cooperation with people to develop digital formats and tangible instructions on labels, packaging and inserts. He holds a PhD from Reading University, UK, and has worked in the pharmaceutical industry ever since.
spacer
Dr Karel van der Waarde
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Horizon Discovery and Fulcrum Therapeutics Form Collaboration for Novel CRISPR-Based Target Discovery in Genetic Diseases

The collaboration will utilize Horizon’s world-leading CRISPR-based screening platform to identify novel targets for regulating gene expression.
More info >>

White Papers

The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology

European Society for Medical Oncology (ESMO)

  The number of cancer patients in Europe is rising and significant advances in basic and applied cancer research are making the provision of optimal care more challenging. The concept of cancer as a systemic, highly heterogeneous and complex disease has increased the awareness that quality cancer care should be provided by a multidisciplinary team (MDT) of highly qualified healthcare professionals. Cancer patients also have the right to benefit from medical progress by receiving optimal treatment from adequately trained and highly skilled medical professionals. Built on the highest standards of professional training and continuing medical education, medical oncology is recognised as an independent medical specialty in many European countries.
More info >>

 
Industry Events

BioPharm America™ 2017—10th Annual International Partnering Conference

26-27 September 2017, 39 Dalton Street, Boston, MA 02116

BioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. Startup companies, established biotech and entrepreneurs from academia attend in search of finance, pharma and development partners.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement